Key result
Stem cell-derived EVs improve cardiac function and reduce infarct size in animal MI models.
Why the study?
Do stem cell-derived extracellular vesicles improve cardiac function and reduce infarct size in animal models of myocardial infarction?
Do stem cell-derived extracellular vesicles improve cardiac function and reduce infarct size in animal models of myocardial infarction?
Stem cell-derived extracellular vesicles show potential for improving cardiac function and reducing infarct size in preclinical models of myocardial infarction.
Supports preclinical efficacy of stem cell-derived EVs in MI models; leaves open clinical translation pending human trials.
Stem cell-derived EVs improve cardiac function and reduce infarct size in myocardial infarction animals, but current pool-up study reveals no associations between common factors and treatment effects.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2019) studied this question. Stem cell-derived extracellular vesicles improve cardiac function and reduce infarct size in animal models of myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: